Hematology NewsSC-PEG comparable to pegaspargase in young ALL/LL patientsJune 1, 2019ALLAggressive LymphomasLeukemia, Myelodysplasia, Transplantation
Hematology NewsLow intensity bridging may be best path to CAR T in adult ALLJune 1, 2019ALLCellular TherapyLeukemia, Myelodysplasia, TransplantationImmuno-oncologyImmunotherapy
Hematology NewsCombo produces ‘best response rate’ after first relapse in kids with AMLJune 1, 2019AMLPediatricsLeukemia, Myelodysplasia, Transplantation
Hematology NewsVenetoclax plus ibrutinib appears to suit elderly and high-risk patients with CLLMay 29, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsGenetic analysis identifies prognostic markers in CLLMay 28, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsNGS comparable to FC for minimal residual disease assessmentMay 17, 2019ALLPediatricsLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDA approves venetoclax/obinutuzumab combo for CLLMay 15, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hospital Physician: Hematology/OncologyManagement of Late Pulmonary Complications After Hematopoietic Stem Cell TransplantationMay 15, 2019Leukemia, Myelodysplasia, Transplantation
Hematology NewsFDA panel not ready to recommend quizartinib approval for FLT3-ITD+ AMLMay 14, 2019AMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsMaster trial seeks to aid drug development for pediatric AMLMay 12, 2019AMLLeukemia, Myelodysplasia, TransplantationPediatrics
Hematology TimesResearchers propose new risk groups for NK-AMLMay 8, 2019AMLLeukemia, Myelodysplasia, TransplantationRare Diseases
Hematology TimesCombo proves most effective in HMA-naive, higher-risk MDSMay 3, 2019Myelodysplastic SyndromeLeukemia, Myelodysplasia, TransplantationAML
Hematology TimesMore abnormal cells linked to poorer ASCT outcomes in MDSMay 3, 2019TransplantationMyelodysplastic SyndromeLeukemia, Myelodysplasia, TransplantationTransplant
Hematology NewsFDA approves ivosidenib frontline for certain AML patientsMay 3, 2019AMLLeukemia, Myelodysplasia, TransplantationRare Diseases
Hematology TimesBiomarker testing may transform treatment of acute GVHDApril 26, 2019TransplantationLeukemia, Myelodysplasia, TransplantationTransplantPatient & Survivor Care
